Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 391.00
-5.00 (-1.26%)
Nov 21, 2025, 1:30 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.3 billion as of November 21, 2025. Its market cap has increased by 48.11% in one year.
Market Cap
21.30B
Enterprise Value
20.88B
Revenue
2.00B
Ranking
n/a
PE Ratio
29.73
Stock Price
391.00
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.30B, an increase of 1,332.00%. That is a compound annual growth rate of 18.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 21.30B | 39.64% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | 4.38B | 0.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.60B |
| PharmaEssentia | 175.86B |
| Lotus Pharmaceutical | 74.82B |
| Bora Pharmaceuticals Co., LTD. | 63.33B |
| Lumosa Therapeutics | 31.76B |
| Oneness Biotech | 28.17B |
| Center Laboratories | 26.61B |
| Pegavision | 24.61B |